In an interview, synthetic biologist Peter Carr explains research on synthetic cells, their potential benefits and hazards, ...

Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...

Cancer is often considered a disease of aging. Older adults are at higher risk because they have had more time to accumulate cellular damage that can trigger tumor formation. But as cancer rates in ...